Literature DB >> 14516521

Prophylactic Therapy for Migraine.

Shazia Afridi1, Holger Kaube.   

Abstract

The term migraine is derived from the ancient Greek word hemicrania introduced by Galen in approximately 200 AD. However, descriptions of "sick headache" have been found dating back to as far as 3000 BC. Despite this, migraine is a condition that still remains underdiagnosed and undertreated. The development of effective abortive agents, such as the triptans, have had a significant impact on migraine management, but there still remains a substantial proportion of migraineurs in whom further medication is required in the form of preventatives. These have the potential to transform the lives of many migraine sufferers.

Entities:  

Year:  2003        PMID: 14516521     DOI: 10.1007/s11940-996-0012-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  43 in total

1.  Fluoxetine for migraine prophylaxis: a double-blind trial.

Authors:  C C d'Amato; V Pizza; T Marmolo; E Giordano; V Alfano; A Nasta
Journal:  Headache       Date:  1999 Nov-Dec       Impact factor: 5.887

2.  MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin.

Authors:  A M Penn; J W Lee; P Thuillier; M Wagner; K M Maclure; M R Menard; L D Hall; N G Kennaway
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

3.  Effect of serotonin in migraine patients.

Authors:  R W KIMBALL; A P FRIEDMAN; E VALLEJO
Journal:  Neurology       Date:  1960-02       Impact factor: 9.910

4.  Low-dose aspirin for migraine prophylaxis in women.

Authors:  I M Benseñor; N R Cook; I M Lee; M J Chown; C H Hennekens; J E Buring
Journal:  Cephalalgia       Date:  2001-04       Impact factor: 6.292

5.  Acetylsalicylic acid vs. metoprolol in migraine prophylaxis--a double-blind cross-over study.

Authors:  K H Grotemeyer; H W Scharafinski; H P Schlake; I W Husstedt
Journal:  Headache       Date:  1990-10       Impact factor: 5.887

6.  Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study.

Authors:  P-H M van der Kuy; F W H M Merkus; J J H M Lohman; J W M ter Berg; P M Hooymans
Journal:  Cephalalgia       Date:  2002-09       Impact factor: 6.292

7.  A gene for familial hemiplegic migraine maps to chromosome 19.

Authors:  A Joutel; M G Bousser; V Biousse; P Labauge; H Chabriat; A Nibbio; J Maciazek; B Meyer; M A Bach; J Weissenbach
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

8.  Verapamil in prophylactic therapy of migraine.

Authors:  H G Markley; J C Cheronis; R W Piepho
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Contingent negative variation and efficacy of beta-blocking agents in migraine.

Authors:  J Schoenen; A Maertens de Noordhout; M Timsit-Berthier; M Timsit
Journal:  Cephalalgia       Date:  1986-12       Impact factor: 6.292

10.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

Authors:  Maurizio De Fusco; Roberto Marconi; Laura Silvestri; Luigia Atorino; Luca Rampoldi; Letterio Morgante; Andrea Ballabio; Paolo Aridon; Giorgio Casari
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

View more
  2 in total

1.  Chronic Daily Headache.

Authors:  James R. Couch
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

2.  The Efficacy of Shinbaro for the Preventive Treatment of Migraine: A Pilot Study.

Authors:  Yesol Jung; Bohee Won; Mijung Lee; Jinyoung Chung; Sung Ju Han; Manho Kim
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-13       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.